Chargement de la fiche…
Chargement de la fiche…
rhumatologie
Praticien hospitalier
Brest (29609)
Sjögren · Biothérapies non-anti-TNF · Lupus
Tout est calculé à partir des sources publiques (RPPS, PubMed, OpenAlex, OpenStreetMap…) — aucun classement éditorial.
Côté patient
Comprendre votre pathologie, exercices à domicile, applications validées, paramédicaux à proximité — gratuit, sans inscription.
DES Rhumatologie · Rhumatologie (SM) — Diplôme d'Études Spécialisées
DE Docteur en médecine — Capacité / Certificat d'Études Spéciales
2026Annals of the rheumatic diseases
PubMed ↗Transcriptomic stratification predicts response to rituximab, abatacept, or the association of hydroxychloroquine and leflunomide in 3 randomised controlled clinical trials of Sjögren's disease
2026Seminars in arthritis and rheumatism
PubMed ↗Patients' perspectives of living with Sjögren disease: A systematic review of qualitative studies from the OMERACT Sjögren disease working group
2026NPJ systems biology and applications
PubMed ↗The SjD Map: an interactive pathway tour into Sjögren's disease signalling mechanisms
2026Rheumatology (Oxford, England)
PubMed ↗The immune cell landscape analysed by imaging mass cytometry in the muscle of patients with inclusion body myositis associated or not with Sjögren's disease
2026Methods in molecular biology (Clifton, N.J.)
PubMed ↗Single-Cell Spatial Transcriptomic of Sjögren's Disease Salivary Glands
2025Rheumatology (Oxford, England)
PubMed ↗Inclusion-body myositis associated with Sjögren's disease: clinical characteristics and comparison with other Sjögren-associated myositis
2025The Journal of rheumatology
PubMed ↗A Systematic Review of Clinical Trial Designs and Outcome Measures in Sjögren Disease Randomized Controlled Trials
2025Annals of the rheumatic diseases
PubMed ↗Primary Sjögren's Disease: a review of unmet need, outcome measures, therapeutic advances and health economic impacts. Lessons from the NEw Clinical Endpoints in primary Sjögren's Syndrome: an Interventional Trial based on stratifYing patients (NECESSITY) Innovative Health Initiative (IHI)
2025Arthritis & rheumatology (Hoboken, N.J.)
PubMed ↗Distinct Pathophysiologic Pathways Support Stratification of Sjögren's Disease Based on Symptoms, Clinical, and Routine Biological Data
2025Rheumatology (Oxford, England)
PubMed ↗Are ultrasound salivary parenchymal lesions more severe in primary Sjögren patients with a longer disease duration? A cross-sectional study
2024Joint bone spine
PubMed ↗"If I have Sjögren's syndrome, I want to know it as early as possible": The perspective of first-degree relatives of patients with Sjögren's syndrome from an international survey
2024Arthritis & rheumatology (Hoboken, N.J.)
PubMed ↗Association of Combined Anti-Ro52/TRIM21 and Anti-Ro60/SSA Antibodies With Increased Sjögren Disease Severity Through Interferon Pathway Activation
2024Seminars in arthritis and rheumatism
PubMed ↗Identification of outcome domains in primary Sjögren's disease: A scoping review by the OMERACT Sjögren disease working group
2024Seminars in arthritis and rheumatism
PubMed ↗The Sjögren's Working Group: The 2023 OMERACT meeting and provisional domain generation
2024Journal of autoimmunity
PubMed ↗High-content multimodal analysis supports the IL-7/IL-7 receptor axis as a relevant therapeutic target in primary Sjögren's syndrome
2024Clinical immunology (Orlando, Fla.)
PubMed ↗Phenotypic, transcriptomic, and spatial characterization of CD45RB(+) naïve mature B cells: Implications in Sjögren's disease
2024RMD open
PubMed ↗Development of a web-based ecological momentary assessment tool to measure day-to-day variability of the symptoms in patients with Sjögren's disease
2023La Revue de medecine interne
PubMed ↗French national diagnostic and care protocol for Sjögren's disease
2026Joint bone spine
PubMed ↗Usefulness of 18F-FDG PET-CT in detecting subclinical arteritis and cancer associated with polymyalgia rheumatica
2026Laboratory investigation; a journal of technical methods and pathology
PubMed ↗Optimal Formalin-Fixed Paraffin-Embedded Sample Preservation for Efficient Staining in Multiplex Imaging
2026The Journal of investigative dermatology
PubMed ↗B-Cell involvement in immune checkpoint inhibitor-induced lichen planus: A comparative analysis with non-drug-related lichen planus
2025La Revue de medecine interne
PubMed ↗[Between the normal and the pathological: The concept of pre-disease applied to systemic autoimmune rheumatic diseases]
2025Annals of the rheumatic diseases
PubMed ↗GM-CSF drives IL-6 production by macrophages in polymyalgia rheumatica
2025BMC bioinformatics
PubMed ↗BiomiX, a user-friendly bioinformatic tool for democratized analysis and integration of multiomics data
2025Drugs & aging
PubMed ↗Aging in Granulomatosis with Polyangiitis and Microscopic Polyangiitis: From Pathophysiology to Clinical Management
2025The Lancet. Rheumatology
PubMed ↗CAR T-cell therapy in autoimmune diseases: where are we and where are we going?
2024Journal of autoimmunity
PubMed ↗Identification of the central tolerance checkpoint for autoreactive proteinase 3(+) B cells in human bone marrow
2024Annals of the rheumatic diseases
PubMed ↗Stratification according to autoantibody status in systemic sclerosis reveals distinct molecular signatures
2024Nature communications
PubMed ↗Maf expression in B cells restricts reactive plasmablast and germinal center B cell expansion
2024Arthritis & rheumatology (Hoboken, N.J.)
PubMed ↗Reply
2024RMD open
PubMed ↗Concordance and agreement between different activity scores in polymyalgia rheumatica
2023Rheumatic diseases clinics of North America
PubMed ↗Treatment Approaches to Granulomatosis with Polyangiitis and Microscopic Polyangiitis
2023Arthritis & rheumatology (Hoboken, N.J.)
PubMed ↗Indication of Activated Senescence Pathways in the Temporal Arteries of Patients With Giant Cell Arteritis
2023Autoimmunity reviews
PubMed ↗Complex relationships of type 2 and type 1 symptoms across various systemic autoimmune diseases
2026Annals of the rheumatic diseases
PubMed ↗Transcriptomic stratification predicts response to rituximab, abatacept, or the association of hydroxychloroquine and leflunomide in 3 randomised controlled clinical trials of Sjögren's disease
2025Arthritis & rheumatology (Hoboken, N.J.)
PubMed ↗Maintenance of Remission After Tocilizumab Withdrawal in Patients With Glucocorticoid-Dependent Polymyalgia Rheumatica
2024European journal of nuclear medicine and molecular imaging
PubMed ↗[(18)F]FDG PET/CT for therapeutic assessment of Abatacept in early-onset polymyalgia rheumatica
2023The Lancet. Rheumatology
PubMed ↗Abatacept in early polymyalgia rheumatica (ALORS): a proof-of-concept, randomised, placebo-controlled, parallel-group trial
2025La Revue de medecine interne
PubMed ↗[Fourteen ways to make B cells the most interesting target in systemic lupus erythematosus]
2024Clinical immunology (Orlando, Fla.)
PubMed ↗Integration of multi-omics analysis reveals metabolic alterations of B lymphocytes in systemic lupus erythematosus
2024Database : the journal of biological databases and curation
PubMed ↗An interactive web application for exploring systemic lupus erythematosus blood transcriptomic diversity
2023Lupus
PubMed ↗Complex relationships between inflammatory manifestations/type 1 and type 2 symptoms in systemic lupus erythematosus: A narrative literature review
2025Rheumatology and therapy
PubMed ↗Prevalence and Significance of the Presence of Anti-transglutaminase and Anti-endomysium Antibodies in Patients with Early Inflammatory Joint Disease
2025Frontiers in medicine
PubMed ↗Commentary: Prevalence and incidence of celiac disease in patients with rheumatoid arthritis: a case-control study based on the RECORD cohort
2026Joint bone spine
PubMed ↗Impact of regulatory events on JAK inhibitor prescribing in rheumatoid arthritis: Insights from the French MAJIK Registry
2025The Lancet. Rheumatology
PubMed ↗Baricitinib in early polymyalgia rheumatica (BACHELOR): a randomised, double-blind, placebo-controlled, parallel-group trial
2025Joint bone spine
PubMed ↗Clinical presentation and treatment response in ACPA-negative rheumatoid arthritis
2026Annals of the rheumatic diseases
PubMed ↗Transcriptomic stratification predicts response to rituximab, abatacept, or the association of hydroxychloroquine and leflunomide in 3 randomised controlled clinical trials of Sjögren's disease
2025Trials
PubMed ↗Evaluation of a nurse-led program for the prevention of complications of long-term glucocorticoids (COCORTICO): study protocol for a randomized trial
2026Joint bone spine
PubMed ↗Practical management of rheumatic immune-related adverse events occurring with immune checkpoint inhibitors: A narrative review
2026Article
The immune cell landscape analyzed by imaging mass cytometry in the muscle of patients with inclusion body myositis associated or not with Sjögren’s disease
Rheumatology
2026Article
Usefulness of 18F-FDG PET-CT in detecting subclinical arteritis and cancer associated with polymyalgia rheumatica
Joint Bone Spine
2026Article
Practical management of rheumatic immune-related adverse events occurring with immune checkpoint inhibitors: A narrative review
Joint Bone Spine
2026Article
Optimal Formalin-Fixed Paraffin Embedded Sample Preservation for Efficient Staining in Multiplex Imaging
Laboratory Investigation
2025Article
Transcriptomic stratification predicts response to rituximab, abatacept, or the association of hydroxychloroquine and leflunomide in 3 randomised controlled clinical trials of Sjögren’s disease
Annals of the Rheumatic Diseases
2025Article
[Fourteen ways to make B cells the most interesting target in systemic lupus erythematosus].
La Revue de Médecine Interne
2025Article
A Systematic Review of Clinical Trial Designs and Outcome Measures in Sjögren Disease Randomized Controlled Trials
Journal of Rheumatology
2025Article
Maintenance of Remission After Tocilizumab Withdrawal in Patients With Glucocorticoid‐Dependent Polymyalgia Rheumatica
Arthritis & rheumatology
Le Point
Un espoir de traitement contre les vascularites à Anca, maladies qui détruisent les organes - Le Point
<a href="https://news.google.com/rss/articles/CBMi3gFBVV95cUxPbkRNVDI2eVBoQTQ5T0VjeEpkTm80WG5RSFJYZ3cyaHNYU1NqOURTWTBVaFpyZW5wUGlkZEVhMnJVNkdVTWtJSTVoeGhLS2Y0RDhUeW1ERmQ2dndmazk3Nk9aemdHd2w5NkZtT2wwM2YyZjFHdW5XWExzTVdzZ1dvLWZDejBCX01TQlFlSEtvVTRjQmhMTW9zLWxTTDlmc0QyQ01PdlAwYmdEZlllTDhSVkFqa3lXTzh6Rm
Ouest-France
Nécrologie. À Brest, Pierre Youinou, brillant chercheur, est décédé - Ouest-France
<a href="https://news.google.com/rss/articles/CBMi4wFBVV95cUxQTklEV3JKOXljSXZtVElCOUs2YVltMHpkUDNTdFFoejZMeGw1bzV4TnpJWDU5Z044MVhxRy1odkU0YmpJeDNiZ2g5aUNRTmZkS0hLYndNUktWa0c3V01VcS02SHdzYmlBZ05SdWRJM2J4OGl4d3R1blpqYVhVdnZNWDlaQlBVa2QwaWxaMDBUaXNRSkVoZ19wUE9kclVVNC02cENoc25EbG9IWkYzcXBBbHVLem50b090ZG
Le Télégramme
Awena. Conférence sur un syndrome méconnu - Le Télégramme
<a href="https://news.google.com/rss/articles/CBMiswFBVV95cUxOMHNaTnl3SWM2QjQwNmZWRTJZaGkzVVB1U2kwVVR4Q3BFLVBwU29ZVk5rcGlxZzhmQWtjXzNzSlZiMlZHOVVZSnZXQ2huZG1HRlBkQjFIZ0JWcVh1RHJWU2JZUjlHbUk3OXRUSFgyZEt3blNXMDNFYVdmamdWc01uRFE4RVBXbU82blluOGs3d2lyVTUwQ3VvVWNQT2pCbnhJM2NxOWx6Zm5TNmp3czhqZ1p1UQ?oc=5" t
Encadrement de doctorants — signal d'activité universitaire.
2021Doctorant : Nedra Chriti
Caractérisation des lymphocytes B auto-réactifs dans le syndrome de Sjögren
Brest
—Doctorant : Rudolf Corty
PreSSto - Pre-Sjögren Syndrome Targeted Immunology Evaluation
Université de Brest (2025-….)
—Doctorant : Alice Tison
Etude des mécanismes immunitaires menant aux effets secondaires immuno-médiés induits par les Inhibiteurs de Checkpoint Immunitaire
Université de Brest (2025-....)
Rhumatologues à proximité